Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) major shareholder D1 Capital Partners L.P. sold 2,852,036 shares of the stock in a transaction dated Wednesday, December 27th. The shares were sold at an average price of $5.86, for a total transaction of $16,712,930.96. Following the completion of the sale, the insider now owns 3,000,000 shares […]
Sight Sciences (NASDAQ:SGHT – Get Free Report) and Medite Cancer Diagnostics (OTCMKTS:MDIT – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Profitability This table compares Sight Sciences and […]
Sight Sciences (NASDAQ:SGHT – Get Free Report) and Medite Cancer Diagnostics (OTCMKTS:MDIT – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk. Valuation & Earnings This table compares Sight […]
Sight Sciences (SGHT) Announces Publication of Successful Results of the SAHARA Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MENLO PARK, Calif., Dec. 18, 2023 Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve.